This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walia, K.
Right arrow Articles by Ganguly, N. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walia, K.
Right arrow Articles by Ganguly, N. K.

 Previous Article  |  Next Article 

Infection and Immunity, October 1999, p. 5215-5222, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Purification and Characterization of Novel Toxin Produced by Vibrio cholerae O1

Kamini Walia,1 Sujata Ghosh,1 Harminder Singh,2 G. B. Nair,3 Amit Ghosh,4 Girish Sahni,4 Harpreet Vohra,1 and Nirmal Kumar Ganguly1,*

Departments of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research,1 Department of Microbiology, PGIMER,2 and Institute of Microbial Technology,4 Chandigarh, and National Institute of Cholera and Enteric Diseases, Calcutta,3 India

Received 21 October 1998/Returned for modification 4 January 1999/Accepted 26 July 1999

Vibrio cholerae WO7 (serogroup O1) isolated from patients with diarrhea produces an extracellular toxin despite the absence of ctx, zot, and ace genes from its genome. The toxin elongates Chinese hamster ovary cells, produces fluid accumulation in ligated rabbit ileal loops, and agglutinates freshly isolated rabbit erythrocytes. Maximal production of this toxin (WO7 toxin) was seen in AKI medium with the pH adjusted to 8.5 at 37°C under shaking conditions. We purified this toxin to homogeneity by sequential ammonium sulfate precipitation, affinity chromatography using a fetuin-Sepharose CL-4B column, and gel filtration chromatography, which increased the specific activity of the toxin by 1.6 × 106-fold. The toxin is heat labile and sensitive to proteases and has a subunit structure consisting of two subunits with molecular masses of about 58 and 40 kDa as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Agglutination of GM1-coated sheep erythrocytes by toxin suggests that GM1 might be the physiologic receptor for WO7 toxin on the enterocytes. An immunodiffusion test between the antiserum raised against the purified WO7 toxin and the purified toxin gave a well-defined precipitation band. In the immunoblot assay, two bands were observed in the 58- and 40-kDa region. At the same time, antiserum against WO7 toxin failed to show any cross-reactivity with cholera toxin or Escherichia coli heat-labile toxin (LT1) in an immunodiffusion test or immunoblot assay. The enterotoxic activity of WO7 toxin could be inhibited by antiserum against purified WO7 toxin. Our results indicate that WO7 toxin is structurally and functionally distinct from other cholera toxins and that the enterotoxic activities expressed by WO7 toxin appear to contribute to the pathogenesis of disease associated with V. cholerae O1 strains.


* Corresponding author. Mailing address: Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012, India. Phone: 91 172 540403. Fax: 91 172 540401 or 745078. E-mail: ganguly{at}ch1.dot.net.in.


Infection and Immunity, October 1999, p. 5215-5222, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Sathyamoorthy, V., Hall, R. H., McCardell, B. A., Kothary, M. H., Ahn, S. J., Ratnayake, S. (2000). Purification and Characterization of a Cytotonic Protein Expressed In Vitro by the Live Cholera Vaccine Candidate CVD 103-HgR. Infect. Immun. 68: 6062-6065 [Abstract] [Full Text]